FollowTheFilings
Managers
Activity
Compare
Newest
Investment
SANGAMO THERAPEUTICS INC
Historical 13F holders
CUSIP
800677106
Type
Equity
Class
COM
Period
13F filings
2026 Q1
3
2025 Q4
6
2025 Q3
7
2025 Q2
7
2025 Q1
12
2024 Q4
9
2024 Q3
7